Koninklijke Philips N.V. (RYLPF)
USD 24.83
(-3.7%)
USD 24.83
(-3.7%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 7.44 Billion EUR | 3.53% |
| 2022 | 7.19 Billion EUR | 0.36% |
| 2021 | 7.16 Billion EUR | -18.37% |
| 2020 | 8.78 Billion EUR | -1.06% |
| 2019 | 8.87 Billion EUR | 3.76% |
| 2018 | 8.55 Billion EUR | 4.56% |
| 2017 | 8.18 Billion EUR | -22.92% |
| 2016 | 10.61 Billion EUR | 7.67% |
| 2015 | 9.85 Billion EUR | 20.11% |
| 2014 | 8.2 Billion EUR | -15.3% |
| 2013 | 9.68 Billion EUR | 2.97% |
| 2012 | 9.4 Billion EUR | 8.81% |
| 2011 | 8.64 Billion EUR | -9.42% |
| 2010 | 9.54 Billion EUR | 18.16% |
| 2009 | 8.07 Billion EUR | -4.58% |
| 2008 | 8.46 Billion EUR | -7.81% |
| 2007 | 9.18 Billion EUR | 10.71% |
| 2006 | 8.29 Billion EUR | -15.44% |
| 2005 | 9.81 Billion EUR | -3.41% |
| 2004 | 10.15 Billion EUR | 7.33% |
| 2003 | 9.46 Billion EUR | -4.64% |
| 2002 | 9.92 Billion EUR | 4.0% |
| 2001 | 9.54 Billion EUR | 3.77% |
| 2000 | 9.19 Billion EUR | 31.78% |
| 1999 | 6.97 Billion EUR | 10.72% |
| 1998 | 6.3 Billion EUR | -25.67% |
| 1997 | 8.47 Billion EUR | 16.08% |
| 1996 | 7.3 Billion EUR | -22.87% |
| 1995 | 9.46 Billion EUR | 1.12% |
| 1994 | 9.36 Billion EUR | 7.04% |
| 1993 | 8.74 Billion EUR | 0.39% |
| 1992 | 8.71 Billion EUR | 9.9% |
| 1991 | 7.92 Billion EUR | 1.71% |
| 1990 | 7.79 Billion EUR | 2.42% |
| 1989 | 7.61 Billion EUR | 7.6% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q3 | 2 Billion EUR | 0.85% |
| 2024 Q2 | 1.98 Billion EUR | 9.59% |
| 2024 Q1 | 1.81 Billion EUR | 0.89% |
| 2023 Q3 | 1.93 Billion EUR | -1.48% |
| 2023 Q1 | 1.75 Billion EUR | -20.94% |
| 2023 FY | 7.44 Billion EUR | 3.53% |
| 2023 Q4 | 1.79 Billion EUR | -6.93% |
| 2023 Q2 | 1.96 Billion EUR | 11.73% |
| 2022 Q2 | 1.73 Billion EUR | 14.63% |
| 2022 Q3 | 1.73 Billion EUR | -0.12% |
| 2022 Q4 | 2.22 Billion EUR | 28.38% |
| 2022 FY | 7.19 Billion EUR | 0.36% |
| 2022 Q1 | 1.51 Billion EUR | -21.22% |
| 2021 Q3 | 1.97 Billion EUR | 10.34% |
| 2021 Q2 | 1.78 Billion EUR | 20.31% |
| 2021 FY | 7.16 Billion EUR | -18.37% |
| 2021 Q4 | 1.91 Billion EUR | -2.84% |
| 2021 Q1 | 1.48 Billion EUR | -48.13% |
| 2020 FY | 8.78 Billion EUR | -1.06% |
| 2020 Q4 | 2.86 Billion EUR | 28.11% |
| 2020 Q1 | 1.84 Billion EUR | -31.84% |
| 2020 Q2 | 1.83 Billion EUR | -0.76% |
| 2020 Q3 | 2.23 Billion EUR | 22.23% |
| 2019 Q4 | 2.7 Billion EUR | 25.61% |
| 2019 FY | 8.87 Billion EUR | 3.76% |
| 2019 Q1 | 1.88 Billion EUR | -29.79% |
| 2019 Q2 | 2.12 Billion EUR | 12.55% |
| 2019 Q3 | 2.15 Billion EUR | 1.41% |
| 2018 Q3 | 2.07 Billion EUR | 3.39% |
| 2018 Q4 | 2.68 Billion EUR | 29.65% |
| 2018 Q2 | 2 Billion EUR | 12.32% |
| 2018 FY | 8.55 Billion EUR | 4.56% |
| 2018 Q1 | 1.78 Billion EUR | -30.29% |
| 2017 Q3 | 1.91 Billion EUR | -0.47% |
| 2017 FY | 8.18 Billion EUR | -22.92% |
| 2017 Q4 | 2.56 Billion EUR | 33.72% |
| 2017 Q2 | 1.92 Billion EUR | -21.24% |
| 2017 Q1 | 2.44 Billion EUR | -23.74% |
| 2016 Q4 | 3.2 Billion EUR | 23.13% |
| 2016 Q2 | 2.53 Billion EUR | 12.0% |
| 2016 Q1 | 2.26 Billion EUR | -19.73% |
| 2016 FY | 10.61 Billion EUR | 7.67% |
| 2016 Q3 | 2.6 Billion EUR | 2.56% |
| 2015 Q4 | 2.82 Billion EUR | 16.56% |
| 2015 Q2 | 2.49 Billion EUR | 17.91% |
| 2015 Q3 | 2.42 Billion EUR | -2.93% |
| 2015 FY | 9.85 Billion EUR | 20.11% |
| 2015 Q1 | 2.11 Billion EUR | -16.33% |
| 2014 FY | 8.2 Billion EUR | -15.3% |
| 2014 Q3 | 1.82 Billion EUR | -16.28% |
| 2014 Q2 | 2.18 Billion EUR | 8.03% |
| 2014 Q1 | 2.01 Billion EUR | -30.0% |
| 2014 Q4 | 2.52 Billion EUR | 38.58% |
| 2013 Q2 | 2.34 Billion EUR | 11.71% |
| 2013 Q1 | 2.1 Billion EUR | -22.1% |
| 2013 Q4 | 2.88 Billion EUR | 22.32% |
| 2013 Q3 | 2.35 Billion EUR | 0.43% |
| 2013 FY | 9.68 Billion EUR | 2.97% |
| 2012 Q4 | 2.69 Billion EUR | 14.91% |
| 2012 Q3 | 2.34 Billion EUR | 4.26% |
| 2012 Q2 | 2.25 Billion EUR | 6.48% |
| 2012 FY | 9.4 Billion EUR | 8.81% |
| 2012 Q1 | 2.11 Billion EUR | -12.32% |
| 2011 Q1 | 2.12 Billion EUR | -22.78% |
| 2011 Q3 | 2.06 Billion EUR | 1.13% |
| 2011 Q4 | 2.41 Billion EUR | 16.7% |
| 2011 FY | 8.64 Billion EUR | -9.42% |
| 2011 Q2 | 2.04 Billion EUR | -3.86% |
| 2010 Q1 | 2.17 Billion EUR | -18.46% |
| 2010 FY | 9.54 Billion EUR | 18.16% |
| 2010 Q4 | 2.75 Billion EUR | 17.86% |
| 2010 Q3 | 2.33 Billion EUR | 2.37% |
| 2010 Q2 | 2.28 Billion EUR | 4.73% |
| 2009 Q4 | 2.67 Billion EUR | 35.17% |
| 2009 FY | 8.07 Billion EUR | -4.58% |
| 2009 Q1 | 1.64 Billion EUR | -32.11% |
| 2009 Q2 | 1.79 Billion EUR | 9.01% |
| 2009 Q3 | 1.97 Billion EUR | 10.39% |
| 2008 Q4 | 2.41 Billion EUR | 24.68% |
| 2008 Q1 | 1.97 Billion EUR | -32.25% |
| 2008 Q2 | 2.17 Billion EUR | 10.02% |
| 2008 Q3 | 1.93 Billion EUR | -10.61% |
| 2008 FY | 8.46 Billion EUR | -7.81% |
| 2007 Q3 | 2.17 Billion EUR | 3.7% |
| 2007 FY | 9.18 Billion EUR | 10.71% |
| 2007 Q1 | 1.99 Billion EUR | -26.15% |
| 2007 Q2 | 2.09 Billion EUR | 5.33% |
| 2007 Q4 | 2.91 Billion EUR | 33.71% |
| 2006 FY | 8.29 Billion EUR | -15.44% |
| 2006 Q4 | 2.69 Billion EUR | 55.91% |
| 2006 Q3 | 1.73 Billion EUR | -30.98% |
| 2006 Q2 | 2.5 Billion EUR | 6.6% |
| 2006 Q1 | 2.35 Billion EUR | -19.95% |
| 2005 Q1 | 2.14 Billion EUR | -31.28% |
| 2005 Q3 | 2.43 Billion EUR | 5.81% |
| 2005 Q2 | 2.29 Billion EUR | 7.33% |
| 2005 Q4 | 2.93 Billion EUR | 20.9% |
| 2005 FY | 9.81 Billion EUR | -3.41% |
| 2004 FY | 10.15 Billion EUR | 7.33% |
| 2004 Q2 | 2.43 Billion EUR | 11.23% |
| 2004 Q3 | 2.41 Billion EUR | -0.99% |
| 2004 Q4 | 3.11 Billion EUR | 29.16% |
| 2004 Q1 | 2.18 Billion EUR | -31.42% |
| 2003 Q2 | 2.07 Billion EUR | -0.51% |
| 2003 Q3 | 2.09 Billion EUR | 0.69% |
| 2003 Q4 | 3.19 Billion EUR | 52.56% |
| 2003 FY | 9.46 Billion EUR | -4.64% |
| 2003 Q1 | 2.08 Billion EUR | -26.6% |
| 2002 Q4 | 2.84 Billion EUR | 32.54% |
| 2002 Q2 | 2.56 Billion EUR | 8.24% |
| 2002 Q1 | 2.36 Billion EUR | -76.83% |
| 2002 FY | 9.92 Billion EUR | 4.0% |
| 2002 Q3 | 2.14 Billion EUR | -16.16% |
| 2001 Q3 | -395.17 Million EUR | 40.87% |
| 2001 Q1 | 412.09 Million EUR | -93.99% |
| 2001 Q2 | -668.3 Million EUR | -262.17% |
| 2001 Q4 | 10.21 Billion EUR | 2685.2% |
| 2001 FY | 9.54 Billion EUR | 3.77% |
| 2000 Q4 | 6.86 Billion EUR | 625.78% |
| 2000 Q3 | 945.47 Million EUR | 30.33% |
| 2000 Q2 | 725.41 Million EUR | 9.36% |
| 2000 Q1 | 663.35 Million EUR | -88.48% |
| 2000 FY | 9.19 Billion EUR | 31.78% |
| 1999 Q4 | 5.75 Billion EUR | 1537.29% |
| 1999 Q1 | 549 Million EUR | -89.54% |
| 1999 Q2 | 318.74 Million EUR | -41.94% |
| 1999 FY | 6.97 Billion EUR | 10.72% |
| 1999 Q3 | 351.66 Million EUR | 10.33% |
| 1998 Q2 | 437.16 Million EUR | 14.0% |
| 1998 Q4 | 5.24 Billion EUR | 2182.25% |
| 1998 FY | 6.3 Billion EUR | -25.67% |
| 1998 Q1 | 383.47 Million EUR | -94.56% |
| 1998 Q3 | 229.95 Million EUR | -47.4% |
| 1997 Q3 | 532.1 Million EUR | 1.94% |
| 1997 FY | 8.47 Billion EUR | 16.08% |
| 1997 Q1 | 383.62 Million EUR | -95.99% |
| 1997 Q2 | 521.97 Million EUR | 36.06% |
| 1997 Q4 | 7.04 Billion EUR | 1223.99% |
| 1996 FY | 7.3 Billion EUR | -22.87% |
| 1996 Q4 | 9.57 Billion EUR | 28.06% |
| 1996 Q3 | 7.47 Billion EUR | -2.14% |
| 1996 Q2 | 7.63 Billion EUR | 0.82% |
| 1996 Q1 | 7.57 Billion EUR | -23.62% |
| 1995 Q2 | 7.05 Billion EUR | 5.97% |
| 1995 Q3 | 7.33 Billion EUR | 4.07% |
| 1995 FY | 9.46 Billion EUR | 1.12% |
| 1995 Q4 | 9.92 Billion EUR | 35.2% |
| 1995 Q1 | 6.65 Billion EUR | -9.08% |
| 1994 Q2 | 7.33 Billion EUR | -3.48% |
| 1994 Q3 | 7.1 Billion EUR | -3.08% |
| 1994 Q4 | 7.31 Billion EUR | 2.94% |
| 1994 FY | 9.36 Billion EUR | 7.04% |
| 1994 Q1 | 7.59 Billion EUR | -2.72% |
| 1993 Q3 | 6.44 Billion EUR | -1.44% |
| 1993 FY | 8.74 Billion EUR | 0.39% |
| 1993 Q2 | 6.53 Billion EUR | 3.64% |
| 1993 Q1 | 6.3 Billion EUR | -33.7% |
| 1993 Q4 | 7.81 Billion EUR | 21.25% |
| 1992 Q3 | 6.03 Billion EUR | -3.4% |
| 1992 FY | 8.71 Billion EUR | 9.9% |
| 1992 Q1 | 5.62 Billion EUR | -9.54% |
| 1992 Q4 | 9.51 Billion EUR | 57.64% |
| 1992 Q2 | 6.24 Billion EUR | 10.99% |
| 1991 Q4 | 6.22 Billion EUR | -25.72% |
| 1991 Q1 | 1.59 Billion EUR | -74.41% |
| 1991 Q2 | 5.84 Billion EUR | 265.85% |
| 1991 Q3 | 8.37 Billion EUR | 43.37% |
| 1991 FY | 7.92 Billion EUR | 1.71% |
| 1990 Q4 | 6.24 Billion EUR | -13.31% |
| 1990 Q2 | 5.85 Billion EUR | 3.15% |
| 1990 Q1 | 5.67 Billion EUR | -30.82% |
| 1990 Q3 | 7.19 Billion EUR | 22.89% |
| 1990 FY | 7.79 Billion EUR | 2.42% |
| 1989 Q1 | 5.22 Billion EUR | 5.7% |
| 1989 Q2 | 5.81 Billion EUR | 11.32% |
| 1989 FY | 7.61 Billion EUR | 7.6% |
| 1989 Q3 | 5.82 Billion EUR | 0.04% |
| 1989 Q4 | 8.21 Billion EUR | 41.07% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| AVITA Medical, Inc. | 41.68 Million USD | -17766.317% |
| Manhattan Scientifics, Inc. | -1000.00 USD | 744800100.0% |
| Össur hf. | 485.57 Million USD | -1433.858% |
| QHSLab, Inc. | 793.6 Thousand USD | -938399.786% |
| Wellstar International, Inc. | - USD | -Infinity% |
| Össur hf. | 485.57 Million USD | -1433.858% |
| CVR Medical Corp. | - USD | -Infinity% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| Escalon Medical Corp. | 5.14 Million USD | -144628.374% |
| Aurora Spine Corporation | 8.21 Million USD | -90604.362% |
| BrainsWay Ltd. | 23.09 Million USD | -32154.991% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| BioElectronics Corporation | 466.38 Thousand USD | -1596853.609% |
| Hamilton Thorne Ltd. | 35.08 Million USD | -21129.413% |
| Vivos Inc. | -6036.00 USD | 123393075.48% |
| Kelyniam Global, Inc. | 2.03 Million USD | -365701.31% |
| REMSleep Holdings, Inc. | -756.73 Thousand USD | 984323.094% |
| Zecotek Photonics Inc. | -195.32 Thousand USD | 3813310.049% |
| Avitar, Inc. | 836.7 Thousand USD | -890061.611% |
| Nanomix Corporation | -69.45 Thousand USD | 10723126.865% |
| EKF Diagnostics Holdings plc | 16.74 Million USD | -44381.008% |
| Theraclion SA | -1.08 Million USD | 689483.877% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Positron Corporation | -353.46 Thousand USD | 2107239.321% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 1.04 Million USD | -712283.011% |
| Lombard Medical, Inc. | 955 Thousand USD | -779795.288% |
| ALR Technologies Inc. | 4945.00 USD | -150616684.631% |
| Stratec SE | 71.58 Million USD | -10303.884% |
| Vycor Medical, Inc. | 1.31 Million USD | -566006.286% |
| Heart Tronics, Inc. | - USD | -Infinity% |
| MicroPort Scientific Corporation | 532.09 Million USD | -1299.742% |
| VMS Rehab Systems, Inc. | -10.44 USD | 71340996268.582% |
| NewCardio, Inc. | 105.1 Thousand USD | -7086281.93% |
| Guided Therapeutics, Inc. | 36 Thousand USD | -20688788.889% |
| Ingen Technologies, Inc. | 268.57 Thousand USD | -2773023.636% |
| Odyssey Group International, Inc. | - USD | -Infinity% |
| CYduct Diagnostics, Inc. | 56.59 Thousand USD | -13160305.697% |
| Wellness Center USA, Inc. | 587.55 Thousand USD | -1267536.797% |
| SANUWAVE Health, Inc. | 14.36 Million USD | -51755.462% |
| IR-Med Inc. | -17 Thousand USD | 43811864.706% |
| Perimeter Medical Imaging AI, Inc. | 206.41 Thousand USD | -3608094.982% |
| Polarean Imaging plc | 335.48 Thousand USD | -2219982.687% |
| United American Healthcare Corporation | -8000.00 USD | 93100100.0% |
| ECGI Holdings, Inc. | - USD | -Infinity% |
| Nu-Med Plus, Inc. | -12.9 Thousand USD | 57736534.109% |
| Capital Group Holdings, Inc. | - USD | -Infinity% |
| ADM Tronics Unlimited, Inc. | 1.09 Million USD | -680675.14% |
| Medical Supply International USA, Inc. | 1.75 Million USD | -423399.924% |
| Urologix, Inc. | 6.09 Million USD | -122138.634% |
| Rapid Therapeutic Science Laboratories, Inc. | - USD | -Infinity% |
| Nexeon MedSystems Inc. | -316.69 Thousand USD | 2351919.281% |
| SS Innovations International, Inc. | 713.44 Thousand USD | -1043845.801% |
| Qualis Innovations, Inc. | - USD | -Infinity% |
| Smith & Nephew plc | 3.91 Billion USD | -90.437% |
| NIOX Group Plc | 28.13 Million USD | -26373.965% |
| Fuse Medical, Inc. | 10.73 Million USD | -69288.042% |
| Broncus Holding Corporation | 7.22 Million USD | -102957.977% |
| Brain Scientific Inc. | 54.32 Thousand USD | -13709978.233% |
| Pressure BioSciences, Inc. | 799.56 Thousand USD | -931410.002% |
| Health Logic Interactive Inc. | - USD | -Infinity% |